252 related articles for article (PubMed ID: 23368969)
1. Comparison of intravitreal vancomycin and daptomycin application in experimental methicillin-resistant Staphylococcus aureus (MRSA) endophthalmitis in rabbits.
Coskun E; Okumus S; Gurler B; Demir T; Bahar AY; Zer Y; Comez A; Tatar MG; Aksoy U; Erbagci I
Cutan Ocul Toxicol; 2013 Sep; 32(3):222-7. PubMed ID: 23368969
[TBL] [Abstract][Full Text] [Related]
2. Daptomycin versus Vancomycin in an Enterococcus faecalis Endophthalmitis Rabbit Model.
Ozcimen M; Kurtoglu MG; Goktas S; Omeroglu E; Sakarya Y; Alpfidan I; Ozcımen S; Sakarya R; Yener HI; Demir LS; Saglam F
Curr Eye Res; 2016; 41(2):232-9. PubMed ID: 25658242
[TBL] [Abstract][Full Text] [Related]
3. Daptomycin versus vancomycin in a methicillin-resistant Staphylococcus aureus endophthalmitis rabbit model: bactericidal effect, safety, and ocular pharmacokinetics.
Lefèvre S; Saleh M; Marcellin L; Subilia A; Bourcier T; Prévost G; Jehl F
Antimicrob Agents Chemother; 2012 May; 56(5):2485-92. PubMed ID: 22371888
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of intravitreal piperacillin/tazobactam in rabbits with experimental Staphylococcus epidermidis endophthalmitis: a comparison with vancomycin.
Ozkiriş A; Evereklioglu C; Eşel D; Akgün H; Erkiliç K
Ophthalmic Res; 2005; 37(3):168-74. PubMed ID: 15942265
[TBL] [Abstract][Full Text] [Related]
5. Treatment of experimental Bacillus cereus endophthalmitis using intravitreal moxifloxacin with or without dexamethasone.
Sakalar YB; Ozekinci S; Celen MK
J Ocul Pharmacol Ther; 2011 Dec; 27(6):593-8. PubMed ID: 21834669
[TBL] [Abstract][Full Text] [Related]
6. Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis.
Ermis SS; Cetinkaya Z; Kiyici H; Inan UU; Ozturk F
Curr Eye Res; 2007 Apr; 32(4):337-44. PubMed ID: 17453955
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of intravitreal administrations of linezolid in an experimental model of S. aureus-related endophthalmitis.
Saleh M; Lefèvre S; Acar N; Bourcier T; Marcellin L; Prévost G; Subilia A; Gaucher D; Jehl F
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4832-41. PubMed ID: 22661478
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis.
Ferrer C; Rodríguez A; Abad JL; Fernandez J; Alió JL
Br J Ophthalmol; 2008 May; 92(5):678-82. PubMed ID: 18211926
[TBL] [Abstract][Full Text] [Related]
9. Effect of intravitreal triamcinolone acetonide in the treatment of experimental Staphylococcus epidermidis endophthalmitis.
Hosseini H; Mehryar M; Eghtedari M; Ahmadi F; Nowroozizadeh S
Curr Eye Res; 2009 Feb; 34(2):145-51. PubMed ID: 19219686
[TBL] [Abstract][Full Text] [Related]
10. Presence of adequate intravitreal concentrations of daptomycin after systemic intravenous administration in a patient with endogenous endophthalmitis.
Sheridan KR; Potoski BA; Shields RK; Nau GJ
Pharmacotherapy; 2010 Dec; 30(12):1247-51. PubMed ID: 21114392
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of daptomycin on experimental methicillin-resistant Staphylococcus aureus keratitis in rabbits.
Mengeloğlu FZ; Küçükbayrak A; Bucak YY; Erdurmuş M; Taş T; Özyalvaçlı G; Bayram R; Bucak Ö; Akdeniz H
J Ocul Pharmacol Ther; 2013 Dec; 29(10):893-9. PubMed ID: 24070366
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
Lefebvre M; Jacqueline C; Amador G; Le Mabecque V; Miegeville A; Potel G; Caillon J; Asseray N
Int J Antimicrob Agents; 2010 Dec; 36(6):542-4. PubMed ID: 20851576
[TBL] [Abstract][Full Text] [Related]
13. Effect of caffeic acid phenethyl ester on treatment of experimentally induced methicillin-resistant Staphylococcus epidermidis endophthalmitis in a rabbit model.
Yildirim O; Yilmaz A; Oz O; Vatansever H; Cinel L; Aslan G; Tamer L; Adigüzel U; Arpaci R; Kanik A; Emekdaş G
Cell Biochem Funct; 2007; 25(6):693-700. PubMed ID: 16981209
[TBL] [Abstract][Full Text] [Related]
14. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus keratitis in rabbits.
Tas T; Kucukbayrak A; Hakyemez IN; Mengeloglu FZ; Simavli H; Ozyalvacli G; Erdurmus M
Cornea; 2013 Jul; 32(7):1052-7. PubMed ID: 23665649
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimental Staphylococcus aureus endophthalmitis.
Engelbert M; Miño de Kaspar H; Thiel M; Grasbon T; Ta CN; Schulze-Schwering M; Klauss V; Kampik A
Graefes Arch Clin Exp Ophthalmol; 2004 Apr; 242(4):313-20. PubMed ID: 14986007
[TBL] [Abstract][Full Text] [Related]
16. A comparison of intravitreal piperacillin/tazobactam with ceftazidime in experimental Pseudomonas aeruginosa endophthalmitis.
Ozkiriş A; Evereklioglu C; Akgün H; Eşel D; Caner F; Erkiliç K
Exp Eye Res; 2005 Mar; 80(3):361-7. PubMed ID: 15721618
[TBL] [Abstract][Full Text] [Related]
17. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.
Moore CL; Osaki-Kiyan P; Haque NZ; Perri MB; Donabedian S; Zervos MJ
Clin Infect Dis; 2012 Jan; 54(1):51-8. PubMed ID: 22109947
[TBL] [Abstract][Full Text] [Related]
18. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.
Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
Am J Ophthalmol; 2005 Sep; 140(3):497-504. PubMed ID: 16083841
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis.
Kim JY; Kim SY
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1742-7. PubMed ID: 21169530
[TBL] [Abstract][Full Text] [Related]
20. Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin and intravitreal dexamethasone.
Smith MA; Sorenson JA; D'Aversa G; Mandelbaum S; Udell I; Harrison W
J Infect Dis; 1997 Feb; 175(2):462-6. PubMed ID: 9203674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
